Avalyn Pharma Inc. (AVLN) stock
AVLNNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026
$27.92−1.84 (-6.18%)
Close on Nov 17, 2026Market cap $1.24BP/E –Yield –
Avalyn Pharma total assets
Total assets on the balance sheet at the end of each period.
Avalyn Pharma's total assets was $425.45M at Jun 30, 2026. For fiscal 2025 it was $148.88M.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $148.88M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $425.45M | – |
| Q1 FY2026 | Mar 31, 2026 | $135.66M | – |
| Q4 FY2025 | Dec 31, 2025 | $148.88M | – |
See a number that looks wrong?